Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System
Open Access
- 28 September 2020
- Vol. 25 (19) , 4454
Abstract
A group of triethylphosphine gold(I) and silver(I) complexes, structurally related to auranofin, were prepared and investigated as potential anticancer drug candidates. The antiproliferative properties of these metal compounds were assessed against two leukemia cell lines, i.e., CCRF-CEM and its multidrug-resistant counterpart, CEM/ADR5000. Interestingly, potent cytotoxic effects were disclosed for both series of compounds against leukemia cells, with IC50 values generally falling in the low-micromolar range, the gold derivatives being on the whole more effective than the silver analogues. Some initial structure-function relationships were drawn. Subsequently, the ability of the study compounds to inhibit the three main catalytic activities of the proteasome was investigated. Different patterns of enzyme inhibition emerged for the various metal complexes. Notably, gold compounds were able to inhibit effectively both the trypsin-like and chymotrypsin-like proteasome activities, being less effective toward the caspase-like catalytic activity. In most cases, a significant selectivity of the study compounds toward the proteasome proteolytic activities was detected when compared to other proteases. The implications of the obtained results are discussed.Keywords
This publication has 32 references indexed in Scilit:
- Selected cytotoxic gold compounds cause significant inhibition of 20S proteasome catalytic activitiesJournal of Inorganic Biochemistry, 2014
- Epigenetic and molecular mechanisms underlying the antileukemic activity of the histone deacetylase inhibitor belinostat in human acute promyelocytic leukemia cellsAnti-Cancer Drugs, 2014
- Peptide‐Based Proteasome Inhibitors in Anticancer Drug DesignMedicinal Research Reviews, 2014
- Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cellsBMB Reports, 2013
- Proteasome Inhibitors: An Expanding Army Attacking a Unique TargetChemistry & Biology, 2012
- The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradationNature Reviews Molecular Cell Biology, 2011
- Prediction of Broad Spectrum Resistance of Tumors towards Anticancer DrugsClinical Cancer Research, 2008
- Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the ProteasomeCancer Research, 2007
- Aziridide‐Based Inhibitors of Cathepsin L: Synthesis, Inhibition Activity, and Docking StudiesChemMedChem, 2006
- Importance of the Different Proteolytic Sites of the Proteasome and the Efficacy of Inhibitors Varies with the Protein SubstrateJournal of Biological Chemistry, 2006